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Monospecific polyclonal antibodies against seven proteins of the 40 S subunit of rat liver ribosomes were used to identify 
ribosomal proteins involved in interaction with initiation factor elF-2 in the quaternary initiation complex [elF-2 x 
GMPPCP x [aH]Met-tRNAf x 40 S ribosomal subunit]. Dimeric immune complexes of 40 S subunits mediated by anti- 
bodies against ribosomal proteins S3a, S13/16, S19 and $24 were found to be unable to bind the ternary initiation com- 
plex [elF-2 x GMPPCP x pH]Met-tRNAf]. In contrast, 40 S dimers mediated by antibodies against proteins $2, $3 
and S 17 were found to bind the ternary complex. Therefore, from the ribosomal proteins tested, only proteins S3a, S 13/ 
16, S!9 and $24 are concluded to be involved in elF-2 binding to the 40 S subunit. 
40 S ribosomal subunit; elF-2 binding; Inhibitory antibody; Ribosomal protein 
1. INTRODUCTION 
The interact ion of  proteins of  the 40 S 
r ibosomal  subunit  with init iat ion factor e lF-2 in 
the quaternary init iat ion complex [elF-2 × GTP  x 
Met- tRNAf  x 40 S subunit] has been investigated 
by crossl inking experiments [1,2] as well as by ap- 
pl icat ion of  ant ibodies against r ibosomal  proteins 
[3,4] (review [5]). Most  of  the proteins hown to be 
involved in e lF-2 binding have been located at the 
surface o f  the 40 S r ibosomal  subunit  by im- 
munoelectron microscopy [6-8].  However,  the 
locat ion of  some of  these proteins deviates con- 
s iderably f rom the locat ion o f  e lF-2 within quater-  
nary init iat ion complexes observed recently by the 
same method [9]. Therefore,  we reinvestigated the 
involvement of  r ibosomal  proteins in the interac- 
t ion between elF-2 and the 40 S r ibosomal  subunit  
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by using polyclonal  ant ibodies against r ibosomal  
proteins, which were shown to be monospeci f ic  by 
immunoblot t ing and were able to form dimeric im- 
mune complexes with 40 S r ibosomal  subunits. 
The results demonstrate that r ibosomal  proteins 
S3a, S13/16, S19 and $24 are involved in eIF-2 
binding, which is in agreement with the observed 
locat ion of  these proteins [7,8] at or near the eIF-2 
binding area [9] of  the 40 S subunit.  
2. MATERIALS  AND METHODS 
2.1. Materials 
Guanylyl ~,'r-methylene)diphosphonate (GMPPCP) and 
total tRNA from yeast was purchased from Boehringer 
(Mannheim), and [JH]methionine (555 GBq per mmol) was ob- 
tained from Amersham (England). 
2.2. Preparations 
The preparation of 40 S ribosomal subunits from rat liver 
[10] and of [3H]Met-tRNAf rom total yeast RNA [11] was 
described earlier. Initiation factor eIF-2 from rat liver was 
prepared according to Nyghrd et al. [12] with some modifica- 
tions of the procedure described recently [9]. Ribosomal pro- 
teins from 40 S subunits were prepared by a procedure 
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including chromatography on CM-cellulose and reversed-phase 
liquid chromatography [13]. Immunization of rabbits as well as 
the purification of antibodies against ribosomal proteins and 
the test for monospecificity b  immunoblotting will be reported 
separately [8]. 
2.3. Assay 
Inhibition of eIF-2 binding to 40 S ribosomal subunits by an- 
tibodies against 40 S proteins was tested by the following pro- 
cedure: 40 S ribosomal subunit x antibody complexes were 
preformed inreaction mixtures of a total volume of 200/~1 con- 
taining 20 mM Tris-HCl, pH 7.5,200 mM KCI, 2 mM MgC12, 
25/~g 40 S subunits and amounts of purified antibodies against 
40 S proteins as given in the legend to fig. 1. The relatively high 
salt concentration was chosen in order to avoid self- 
dimerisation of 40 S subunits. The reaction mixtures were in- 
cubated for 20 min at 37°C and 60 min at 0°C to allow immune 
complex formation. Prior to the addition of the ternary initia- 
tion complex, the samples were diluted with an equal volume of 
20 mM Tris-HCl, pH 7.5, in order to adjust he KCI concentra- 
tion to 100 mM. 
Ternary initiation complexes [eIF-2 × GMPPCP x Met- 
tRNAd were formed in reaction mixtures of a total volume of 
100/~l containing 20raM Tris-HCl, pH 7.5, 100mM KC1, 
2 mM 2-mercaptoethanol, 0.5 mM GMPPCP, 16 pmol 
[3H]Met-tRNAf and 20/~g purified eIF-2 each, by incubation 
for l0 min at 37°C. Subsequently, the ternary complexes were 
mixed with the preformed 40 S immune complexes, the MgC12 
concentration was adjusted to 7 raM, and the mixture was in- 
cubated for 5 min at 37°C in order to allow formation of 
quaternary initiation complexes. 
The incubation mixtures were then analyzed by centrifuga- 
tion in 10-30°70 sucrose gradients containing 20 mM Tris-HCl, 
pH 7.5, 100 mM KC1, 5 mM MgCI2 in a Spinco rotor SW 40 
for 16 h at 23000 rpm at 2°C. The gradients were monitored at 
260 nm in a Gilford 2400 spectrophotometer, fractionated and 
counted for radioactivity in a scintillation mixture containing 
methanol and toluene scintillator. Under these conditions, 
16600 dpm per pmol [3H]methionine were counted. 
3. RESULTS AND DISCUSSION 
The part ic ipat ion of  r ibosomal  proteins $2, $3, 
S3a, S13/16, S17, S19 and $24 in the interact ion of  
the 40 S r ibosomal  subunit  with init iat ion factor 
eIF-2 was investigated by testing the inhibitory ef- 
fect of  monospeci f ic  polyclonal  ant ibodies against 
these proteins on the binding of  ternary init iat ion 
complexes [eIF-2 x GMPPCP x [3H]Met-tRNAf] 
to 40 S subunits. Details o f  the experimental  pro-  
cedure are given in section 2. 
F rom the results presented in fig. 1 it is obvious 
that all appl ied ant ibody preparat ions are able to 
form dimeric immune complexes, however, to 
varying extents. The dimeric 40 S complexes 
mediated by the ant ibodies used dif fer con- 
s iderably in their abi l i ty to bind [3H]Met-tRNAy, 
which is a direct ref lection o f  the extent of  eIF-2 
binding. In contrast,  the remaining monomer ic  
40 S particles are in each case able to bind Met- 
tRNAf.  For  evaluat ion o f  the inhibitory effect o f  
the individual ant ibodies only the dimeric 40 S 
complexes are considered, because dimerisat ion is 
largely dependent on ant ibody binding to 40 S 
subunits. The relative amount  of  40 S dimers 
formed in the absence o f  ant ibodies (control:  11 070 
dimers) is signif icantly lower than that formed in 
the presence of  the ant ibody preparat ion with the 
lowest d imer isat ion  eff iciency (ant i -S17:20°70 
r imers) .  Furthermore,  the inabi l i ty of  40 S dimers 
formed by anti-S3a, anti -S13/16, anti-S19 and 
anti-S24 ant ibodies to bind Met - tRNAf  underl ines 
the ant ibody dependence of  the format ion of  40 S 
dimers. 
A quantitat ive valuat ion of  the observed Met- 
tRNAf  binding to the 40 S dimers is given in fig.2. 
It is obvious that the ant ibodies anti-S3a, anti- 
S13/16, anti-S19 and anti-S24 clearly inhibit  eIF-2 
binding to 40 S subunits. In contrast,  40 S dimers 
formed by the ant ibodies anti-S2, anti-S3 and anti-  
S17 are still able to bind Met - tRNAf  to about  the 
same extent as the 40 S monomers  of  the control .  
It is concluded that r ibosomal  proteins S3a, 
S13/16, S19 and $24 are involved in eIF-2 binding, 
whereas $2, $3 and S17 are not. 
These results agree only part ia l ly with the con- 
clusions drawn from our earl ier experiments [3,4], 
according to which proteins $3, $6, $13 and S19 
are involved in eIF-2 binding. There is good agree- 
ment of  the results concerning proteins S13 and 
S19. On the other hand, the results about  protein 
$3  were contradictory.  Now, we would consider 
the former results with some reservation, because: 
(i) some of  the ant ibodies against r ibosomal  pro-  
teins used in those experiments howed a certain 
unspecif icity as revealed now by immunoblot t ing 
(Stahl, J . ,  unpubl ished);  (ii) gradient centr i fuga- 
t ion analysis was per formed under high 
hydrostat ic  pressure (60000 rpm, SW 60 rotor),  
under which d isrupt ion of  dimeric 40 S immune 
complexes could not be excluded, and only 
monomer ic  40 S subunits were considered to 
evaluate inhibit ion of  Met - tRNAf  binding by the 
dif ferent antibodies;  (iii) the results reported in this 
paper are supported by the observed locat ions o f  
protein $3 and o f  eIF-2 (see below; fig.3). 
Concerning r ibosomal  protein $6, we were not 
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Fig.l. Sucrose gradient analysis of 40 S immune complexes prepared using antibodies against ribosomal proteins as indicated, and 
incubated with ternary initiation complexes [eIF-2 × GMPPCP x [3H]Met-tRNAd as described indetail in section 2. Antibodies were 
applied in the following amounts: 123/~g anti-S2, 70/~g anti-S3, 25/~g anti-S3a, 222/~g anti-Sl3/16, 232 #g anti-S17, 104/~g anti-Sl9, 
222/~g anti-S24. The distributions of [3H]Met-tRNAf (~. ~.) and of the absorbance at 260 nm (...) in the gradients are shown. 
Arrows indicate positions of dimeric 40 S immune complexes. Control: without antibodies. 
able to repeat he experiment under the conditions 
described in this paper, because some of the an- 
t ibody preparations used in the earlier study, anti- 
$6 included, were after repurification no longer 
able to form dimeric immune complexes with 40 S 
ribosomal subunits. But our earlier conclusion that 
protein $6 participates in eIF-2 binding [4] is sup- 
ported by crosslinking experiments [1,2]. 
The location of  the respective ribosomal pro- 
teins on the surface of  the 40 S subunit as 
demonstrated by immunoelectron microscopy 
[6-8] together with the recently observed 
eIF-2-binding area [9] are shown in a schematic 
drawing in fig.3. These results clearly support the 
conclusion drawn from the inhibition experiments 
with antibodies (figs 1 and 2). Ribosomal proteins 
S3a and $24 are (at least partially) located at the 
eIF-2-binding region, whereas proteins $2 and $3, 
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Fig.2. Specific Met-tRNArbinding activity of the dimeric 
immune complexes of 40 S subunits formed by antibodies 
against different ribosomal proteins. The columns represent 
quotients between the amount of Met-tRNAf and the amount of 
40 S subunit present in the dimeric complexes as calculated 
from the experiments documented in fig.l. As a control, Met- 
tRNAf binding to monomeric 40 S particles in the absence of 
antibodies (control gradient in fig.l) is shown. 
the antibodies which do not inhibit eIF-2 binding, 
are located on the opposite side of the 40 S particle 
(fig.3). Proteins S13/16, S17 and S19 are closely 
neighboured in a distinct region of the 'head' of 
the 40 S subunit near one end of the eIF-2-binding 
site (fig.3). Our observation that only antibodies 
against one of these ribosomal proteins (anti-S17) 
are nearly unable to inhibit eIF-2 binding (figs 1 
and 2) suggests a very distal ocation of S 17 in this 
particular egion at the end of the eIF-2-binding 
area. 
Another approach to investigate he interaction 
between 40 S ribosomal proteins and initiation fac- 
tor eIF-2 was chemical crosslinking [1,2]. The 
results of the experiments indicated that eIF-2 in- 
teracts with ribosomal proteins $3, S3a, $6, 
S13/16, S19 and $24. (The nomenclature of 
ribosomal proteins used in this paper follows that 
of McConkey et al. [14], whereas in [1,3] an earlier 
nomenclature was applied [15].) This is in agree- 
ment with the results of our antibody inhibition ex- 
periments, with the exception of protein $3. The 
observed crosslinking of protein $3 to eIF-2 [1] 
could be explained by indirect crosslinking via pro- 
tein S3a, because in all crosslinking studies with 
40 S ribosomal subunits proteins $3 and S3a were 
identified as neighboured proteins (for review see 
[51). 
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Fig.3. Three-dimensional model of the 40 S ribosomal subunit 
demonstrating the location of the antibody-binding sites of 
ribosomal proteins $2, $3, S3a, S13/16, S17, S19 and $24 
(results taken from [6-8]) and the location of the elF-2-binding 
area (results taken from [9]). 
In general, the data obtained by chemical 
crosslinking, by the antibody inhibition assay, and 
by immunoelectron microscopy are in good agree- 
ment, and the picture merges that at least proteins 
S3a, S13/16, S19 and $24 are involved in eIF-2 
binding to the 40 S ribosomal subunit. 
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